Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Casali, P.
Right arrow Articles by Cavalli, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Casali, P.
Right arrow Articles by Cavalli, F., Dr
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 10:769-773, 1999
© 1999 European Society for Medical Oncology

other

START: A European state-of-the-art on-line instrument for clinical oncologists

P. Casali1,, L. Licitra1, C. Tondini1, F. de Braud2, P. Bruzzi3, A. Costa4 and F. Cavalli, Dr5

1Ihtituto Nazionale per lo Studio e la Cura dei Tumori
2European Institute of Oncology Milan
3Istituto Nazionale per la Ricerca sul Cancro Genoa
4European School of Oncology Milan, Italy
5Ospedale S. Giovanni Bellinzona, Switzerland

Correspondence to: Istituto NazionaleTumori, viaVenezian, 1, 1-20133 Milan, Italy. E-mail: casali{at}istitutotumori.mi.it

START (‘State-of-the-Art Oncology in Europe’), a freely available resource on the Internet, is a European ‘information base’ of current clinical approaches to human tumours. Its aim is to help clinical oncologists make appropriate clinical decisions by providing them with updated information reflecting state-of-the-art cancer treatment as perceived by the European oncology community. It is based upon contributions from authors and internal reviewers from all over Europe as selected by START'S editorial board under the supervision of an advisory board and a scientific committee. Close collaborations with the main European cancer societies are ongoing. An external feedback process augments the mechanisms for rendering START a truly European instrument. START is concerned with evidence-based cancer medicine, and the main clinical options are thus codified and their bases indicated in accord with a scale worked out from the perspective of clinical decision-making. Therapeutic options may be ‘standard’, ‘investigational’, or ‘suitable for individual clinical use’ (within the context of a decision made jointly by the patient and the physician). The goal of instruments such as START is to improve the quality of patient care. In addition, START hopes to make contributions to the methodology by which medical research is transformed into clinical decisions.

decision making, diffusion of innovation, evidence-based medicine, neoplasms/diagnosis, neoplasms/therapy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
C. Trope and J. Kaern
Adjuvant Chemotherapy for Early-Stage Ovarian Cancer: Review of the Literature
J. Clin. Oncol., July 10, 2007; 25(20): 2909 - 2920.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. Jefford, K.-A. Phillips, and M. H.N. Tattersall
An Online Educational Facility for Medical Oncology Trainees: www.vmotg.org
J. Clin. Oncol., May 1, 2001; 19(9): 2566 - 2569.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.